Univest
Univest
  • Markets

Dishman Carbogen Amcis (DCAL) 52 Week Low Streak: Why DCAL Keeps Trading Near Its Yearly Low

  • November 20, 2026
  • Posted by: Chaitanya Auti
  • Category: News
No Comments
Dishman Carbogen Amcis 52 Week Low Streak
Dishman Carbogen Amcis Ltd. (DCAL) share price is trading within 2% of its 52-week low today and stood at Rs 116.7, down 1.6% from the previous close. Market cap was Rs 1,901 crore.

Dishman Carbogen Amcis Ltd. (DCAL) has now traded within 2% of its 52-week low for its second straight session, with the cumulative move across this streak at -3.75%. At 9:23 AM IST, the stock was trading at Rs 116.7 after touching a low of Rs 115.2. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued weakness.

Compared with the previous close of Rs 118.6, DCAL was down Rs 1.9, or 1.6%, and moved between Rs 115.2 and Rs 118.5 during the morning session. The opening price was Rs 115.2, which also marked the day’s low, while the current price sat near the upper end of the intraday range. With a market capitalisation of Rs 1,901 crore, the repeated-low pattern is more meaningful than a single-day slip because it shows that the stock has stayed near its yearly low across multiple sessions, rather than only briefly drifting lower.

Table of Contents

Toggle
  • Dishman Carbogen Amcis 52 Week Low Streak: Consecutive Low Analysis
  • What The Repeated 52-Week Lows Show
  • Dishman Carbogen Amcis Ltd. (DCAL) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching
  • About The Company
  • Frequently Asked Questions
    • What does a Dishman Carbogen Amcis 52 Week Low Streak mean?
    • How much has DCAL moved across this streak?
    • Is there a company-specific reason for the latest fall?
    • How did Dishman Carbogen Amcis trade today?
    • Is Dishman Carbogen Amcis cheap on valuation?
    • How does DCAL compare with healthcare peers?
    • What should investors monitor next?
    • Why is the Dishman Carbogen Amcis 52 Week Low Streak important for readers?
  • Track Dishman Carbogen Amcis Ltd. (DCAL) Share Price on Univest

Dishman Carbogen Amcis 52 Week Low Streak: Consecutive Low Analysis

Metric Value
Current Price Rs 116.7
Previous Close Rs 118.6
Today's Move Rs -1.9 (-1.6%)
Open Rs 115.2
High Rs 118.5
Low Rs 115.2
Market Capitalisation Rs 1,901 crore

Dishman Carbogen Amcis Ltd. (DCAL) traded at Rs 116.7 versus the previous close of Rs 118.6, a fall of 1.6%. The stock opened at Rs 115.2, reached a high of Rs 118.5, touched a low of Rs 115.2.

Dishman Carbogen Amcis share price today stayed under pressure as DCAL traded at Rs 116.7, below the previous close of Rs 118.6. That left the stock down Rs 1.9, or 1.6%, in morning trade. The day opened at Rs 115.2 and touched a high of Rs 118.5, while the low was also Rs 115.2, placing the current price closer to the upper end of the intraday band. For readers tracking Dishman Carbogen Amcis share price today, the key takeaway is not just the smaller intraday move, but the fact that the stock remains near its 52-week low for a second straight session. The market capitalisation stood at Rs 1,901 crore, which places the company in the broader mid-sized bracket by value, even as the share price continues to reflect persistent weakness. In the context of Dishman Carbogen Amcis stock news, the latest price action keeps the focus on repeated downside rather than any sign of a turnaround.

What The Repeated 52-Week Lows Show

DCAL has now stayed within 2% of its 52-week low for the second straight session, and that pattern matters more than a one-session move. The cumulative decline across the streak is -3.75%, which tells investors that the weakness has been sustained rather than isolated. This is the core distinction in a Dishman Carbogen Amcis 52 Week Low Streak story: the stock is not simply reacting to one trading day, but continuing to hover near its one-year low across consecutive sessions.

At this stage, the latest Univest data confirms the pattern, but it does not identify a company-specific trigger. That means the market can observe the repeated low-price behaviour, yet should avoid reading a precise cause into it without additional disclosure. For anyone following Stocks Hitting 52 Week Lows, this kind of setup often deserves more attention than a single print because it signals that the stock price has remained weak through more than one trading session. In practical terms, the Dishman Carbogen Amcis 52 Week Low Streak keeps the focus on persistence, not just intensity, of the downside.

Dishman Carbogen Amcis Ltd. (DCAL) Fundamental Analysis

Metric Value
Market Capitalisation Rs 1,901 crore
P/E Ratio 16.48x
P/B Ratio 0.28x
ROE 1.56%
ROCE 3.21%
EPS Rs -7.39
Book Value Per Share Rs 425.5
Dividend Yield 0%

Dishman Carbogen Amcis Ltd. (DCAL) fundamental metrics show P/E 16.48x, P/B 0.28x, ROE 1.56%, ROCE 3.21%. These figures provide context only and are not a buy or sell signal.

Dishman Carbogen Amcis Ltd. has a market capitalisation of Rs 1,901 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 16.48x, P/B at 0.28x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 1.56% and ROCE of 3.21%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -7.39, book value per share of Rs 425.5, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.6x, median ROE of 11.22%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 16.48x
Benchmark Median P/E 26.6x
Benchmark Average P/E 51.31x
Benchmark P/E Range 0x to 1,399.41x
Company P/B Ratio 0.28x
Benchmark Median P/B 2.84x
Company ROE 1.56%
Benchmark Median ROE 11.22%
Company ROCE 3.21%
Benchmark Median ROCE 13.1%
Company Market Capitalisation Rs 1,901 crore
Benchmark Median Market Cap Rs 742.37 crore

Dishman Carbogen Amcis Ltd. (DCAL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Dishman Carbogen Amcis Ltd. (DCAL) has a P/E ratio of 16.48x, which is below the benchmark median of 26.6x, a difference of -38.05%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Dishman Carbogen Amcis Ltd. (DCAL) has a ROE of 1.56%, which is below the benchmark median of 11.22%, a difference of -86.1%. Dishman Carbogen Amcis Ltd. (DCAL) has a ROCE of 3.21%, which is below the benchmark median of 13.1%, a difference of -75.5%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Venus Remedies Ltd. VENUSREM 1,937.28 16.48 2.85 16.79 21.88
Hester Biosciences Ltd. HESTERBIO 1,984.91 14.05 4.27 17.05 16.21
Beta Drugs Ltd. BETA 2,004.38 37.79 4.48 18.78 19.16
Windlas Biotech Ltd. WINDLAS 2,040.1 30.46 3.61 12.52 16.06
NGL Fine-Chem Ltd. NGLFINE 1,763.49 26.97 4.75 15.74 16.88

Dishman Carbogen Amcis Ltd. (DCAL) has a P/E ratio of 16.48x compared with the displayed peer median of 26.97x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 1.56% compares with a peer median of 16.79% across the companies shown in the table. ROCE stood at 3.21% versus the displayed peer median of 16.88%, providing a capital-efficiency comparison. Dishman Carbogen Amcis Ltd. (DCAL) has a market capitalisation of Rs 1,901 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching

  • DCAL is in a second straight session of trading within 2% of its 52-week low, keeping the focus on repeated weakness rather than a one-day move.
  • The cumulative streak move of -3.75% shows that the downside has persisted across sessions.
  • The stock’s P/B of 0.28 is far below the healthcare peer median, but profitability remains weak.
  • ROE of 1.56% and ROCE of 3.21% are well under the industry medians, which matters for Dishman Carbogen Amcis Fundamental Analysis.
  • Investors tracking DCAL Share Price Today may watch whether the stock stays near the yearly low or begins to move away from that range.

About The Company

Dishman Carbogen Amcis Ltd. is part of the Healthcare sector and operates in the Pharmaceuticals & Drugs industry. The company has a market capitalisation of Rs 1,901 crore and is followed by investors for its share price behaviour, valuation profile and operating performance. In the current phase, the most relevant numbers are the low P/B, the subdued return ratios and the repeated near-low trading pattern. That combination makes Dishman Carbogen Amcis Company News and Dishman Carbogen Amcis Share Price Update relevant for readers who want to understand the stock beyond a single intraday move.

For market participants, the key question is not whether the stock has had one weak print, but whether the Dishman Carbogen Amcis 52 Week Low Streak continues or starts to ease. The company’s industry context, valuation ratios and earnings profile will remain central to that assessment.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.

Frequently Asked Questions

What does a Dishman Carbogen Amcis 52 Week Low Streak mean?

Ans. It means DCAL has traded within 2% of its 52-week low for multiple consecutive sessions. In this case, the stock has done so for its second straight session, which shows repeated weakness rather than a one-off move.

How much has DCAL moved across this streak?

Ans. The cumulative move across the streak is -3.75%. That figure reflects the repeated near-low trading pattern over the two sessions and is more useful than looking at only one day’s price change.

Is there a company-specific reason for the latest fall?

Ans. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause. Investors should treat the move as a verified price pattern unless and until fresh company or market disclosure explains it.

How did Dishman Carbogen Amcis trade today?

Ans. DCAL was trading at Rs 116.7 after opening at Rs 115.2 and touching a high of Rs 118.5. The previous close was Rs 118.6, so the stock was down Rs 1.9, or 1.6%, in morning trade.

Is Dishman Carbogen Amcis cheap on valuation?

Ans. The stock trades at a P/E of 16.48 and a P/B of 0.28, which is below the healthcare peer median on both measures. However, the weak ROE and ROCE mean investors should read valuation together with profitability, not in isolation.

How does DCAL compare with healthcare peers?

Ans. DCAL’s valuation is lower than many peers, but its return ratios are also much weaker. Several peer companies in the same industry have stronger ROE and ROCE, which helps explain why they trade at higher multiples.

What should investors monitor next?

Ans. Investors can watch whether the stock continues to trade near its one-year low or starts moving away from that band. They should also track company financial performance, profitability trends and any fresh stock-specific disclosure.

Why is the Dishman Carbogen Amcis 52 Week Low Streak important for readers?

Ans. It highlights a multi-session pattern, not just a single weak price point. For readers following Dishman Carbogen Amcis 52 Week Low Streak updates, that distinction helps separate a brief move from a more persistent decline story.

Track Dishman Carbogen Amcis Ltd. (DCAL) Share Price on Univest

Use Dishman Carbogen Amcis Ltd. (DCAL) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.



Leave a Reply Cancel reply